Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish ...

Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of their ...

One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...

--"The 2025 forecast will command the most attention in the annual accounts," Hansen said. "The addition of production capacity will continue to be the guiding principle for the full-year forecast." ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

The Mayo Clinic said the supplement “may be safe when taken in recommended amounts” with the main side effects including ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...